Pirfenidone in rheumatoid arthritis-associated interstitial lung disease

Lancet Respir Med. 2023 Jun;11(6):e51. doi: 10.1016/S2213-2600(23)00130-3. Epub 2023 Mar 29.

Authors

Niels Graudal¹, Christoffer Tandrup Nielsen², Jesper Lindhardsen²

Affiliations

¹ Department of Rheumatology, Copenhagen University Hospital, Rigshospitalet, DK 2100 Copenhagen, Denmark. Electronic address: graudal@dadlnet.dk.
² Department of Rheumatology, Copenhagen University Hospital, Rigshospitalet, DK 2100 Copenhagen, Denmark.

PMID: 37003283
DOI: 10.1016/S2213-2600(23)00130-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Arthritis, Rheumatoid* / complications
Arthritis, Rheumatoid* / drug therapy
Humans
Lung
Lung Diseases, Interstitial* / complications
Lung Diseases, Interstitial* / etiology
Pyridones / therapeutic use

Substances

pirfenidone
Pyridones